¥3.84   ( %)
前日收盘: 当日成交量(股): 当日最高: 总股本:1564.55万
当日开盘: 当日成交额(元): 当日最低: 流通股本:
市盈率(动/静):0/0 市净率:0 市销率:0 总市值:6007.89万
52周最高:14.79 52周最低:3.83 转让方式: 单位:美元
$BioXcel(BTAI)$
  • 还可以输入
  • 20016

BioXcel(BTAI) 12月15日 10时53分

公告 BioXcel Therapeutics, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Mehta Vimal
公告日:2018-12-14, 内部交易人:Mehta Vimal, 与发行人关系:CEO, President, Secretary/董事/高管/, 操作:买入,2000(股)Common Stock,均价$4.3830; 报告日:2018-12-14, SEC Accession No. 0001104659-18-073106, File:https://www.sec.gov/Archives/edgar/data/1720893/000110465918073106/0001104659-18-073106-index.htm $BioXcel(BTAI)$
查看全文

BioXcel(BTAI) 12月13日 11时06分

BioXcel(BTAI) 12月13日 03时46分

BioXcel(BTAI) 12月13日 01时57分

新闻 BioXcel Therapeutics Announces FDA Acceptance of IND for Lead Neuroscience Candidate, BXCL501 for the Acute Treatment of Agitation First-in-human pharmacokinetic (bioav ......  url.vc.watch/nS7K
查看全文

BioXcel(BTAI) 12月08日 11时20分

公告 BioXcel Therapeutics, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:MUELLER PETER
公告日:2018-12-07, 内部交易人:MUELLER PETER, 与发行人关系:董事/, 操作:买入,8795(股)Common Stock,均价$5.0080; 报告日:2018-12-06, SEC Accession No. 0001104659-18-071881, File:https://www.sec.gov/Archives/edgar/data/1720893/000110465918071881/0001104659-18-071881-index.htm $BioXcel(BTAI)$
查看全文

BioXcel(BTAI) 12月07日 11时19分

公告 BioXcel Therapeutics, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:MUELLER PETER
公告日:2018-12-06, 内部交易人:MUELLER PETER, 与发行人关系:董事/, 操作:买入,4007(股)Common Stock,均价$5.1271; 报告日:2018-12-04, SEC Accession No. 0001104659-18-071741, File:https://www.sec.gov/Archives/edgar/data/1720893/000110465918071741/0001104659-18-071741-index.htm $BioXcel(BTAI)$
查看全文

BioXcel(BTAI) 12月07日 02时16分

公告 BioXcel Therapeutics, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Yocca Frank
公告日:2018-12-06, 内部交易人:Yocca Frank, 与发行人关系:Chief Scientific Officer/高管/, 操作:买入,900(股)Common Stock,均价$5.2136; 报告日:2018-12-03, SEC Accession No. 0001104659-18-071465, File:https://www.sec.gov/Archives/edgar/data/1720893/000110465918071465/0001104659-18-071465-index.htm $BioXcel(BTAI)$
查看全文

BioXcel(BTAI) 12月05日 18时43分

公告 BioXcel Therapeutics, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Mehta Vimal
公告日:2018-12-04, 内部交易人:Mehta Vimal, 与发行人关系:CEO, President, Secretary/董事/高管/, 操作:买入,1000(股)Common Stock,均价$5.1200; 报告日:2018-12-04, SEC Accession No. 0001104659-18-071405, File:https://www.sec.gov/Archives/edgar/data/1720893/000110465918071405/0001104659-18-071405-index.htm $BioXcel(BTAI)$
查看全文

BioXcel(BTAI) 12月05日 18时43分

公告 BioXcel Therapeutics, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Mehta Vimal
公告日:2018-12-04, 内部交易人:Mehta Vimal, 与发行人关系:CEO, President, Secretary/董事/高管/, 操作:买入,1000(股)Common Stock,均价$5.1650; 报告日:2018-12-03, SEC Accession No. 0001104659-18-071220, File:https://www.sec.gov/Archives/edgar/data/1720893/000110465918071220/0001104659-18-071220-index.htm $BioXcel(BTAI)$
查看全文

BioXcel(BTAI) 12月05日 18时42分

公告 BioXcel Therapeutics, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Steinhart Richard I
公告日:2018-12-04, 内部交易人:Steinhart Richard I, 与发行人关系:Chief Financial Officer/高管/, 操作:买入,500(股)Common Stock,均价$5.1999; 报告日:2018-12-03, SEC Accession No. 0001104659-18-071215, File:https://www.sec.gov/Archives/edgar/data/1720893/000110465918071215/0001104659-18-071215-index.htm $BioXcel(BTAI)$
查看全文

BioXcel(BTAI) 12月04日 00时23分

新闻 BioXcel Therapeutics to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference NEW HAVEN, Conn., Dec. 03, 2018 (GLOBE NEWSWIRE) -- BioXcel ......  url.vc.watch/nIdT
查看全文

BioXcel(BTAI) 12月01日 11时42分

公告 BioXcel Therapeutics, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Steinhart Richard I
公告日:2018-11-30, 内部交易人:Steinhart Richard I, 与发行人关系:Chief Financial Officer/高管/, 操作:买入,500(股)Common Stock,均价$5.0000; 报告日:2018-11-30, SEC Accession No. 0001104659-18-070876, File:https://www.sec.gov/Archives/edgar/data/1720893/000110465918070876/0001104659-18-070876-index.htm $BioXcel(BTAI)$
查看全文

BioXcel(BTAI) 12月01日 11时42分

公告 BioXcel Therapeutics, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Yocca Frank
公告日:2018-11-30, 内部交易人:Yocca Frank, 与发行人关系:Chief Scientific Officer/高管/, 操作:买入,450(股)Common Stock,均价$5.1990; 报告日:2018-11-30, SEC Accession No. 0001104659-18-070875, File:https://www.sec.gov/Archives/edgar/data/1720893/000110465918070875/0001104659-18-070875-index.htm $BioXcel(BTAI)$
查看全文

BioXcel(BTAI) 12月01日 11时42分

公告 BioXcel Therapeutics, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Nandabalan Krishnan
公告日:2018-11-30, 内部交易人:Nandabalan Krishnan, 与发行人关系:董事/10%持股人/, 操作:买入,1000(股)Common Stock,均价$4.9150; 报告日:2018-11-29, SEC Accession No. 0001104659-18-070832, File:https://www.sec.gov/Archives/edgar/data/1720893/000110465918070832/0001104659-18-070832-index.htm $BioXcel(BTAI)$
查看全文

BioXcel(BTAI) 12月01日 11时42分

公告 BioXcel Therapeutics, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Mehta Vimal
公告日:2018-11-30, 内部交易人:Mehta Vimal, 与发行人关系:CEO, President, Secretary/董事/高管/, 操作:买入,1000(股)Common Stock,均价$5.1040; 报告日:2018-11-30, SEC Accession No. 0001104659-18-070826, File:https://www.sec.gov/Archives/edgar/data/1720893/000110465918070826/0001104659-18-070826-index.htm $BioXcel(BTAI)$
查看全文

BioXcel(BTAI) 12月01日 03时58分

公告 BioXcel Therapeutics, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Yocca Frank
公告日:2018-11-30, 内部交易人:Yocca Frank, 与发行人关系:Chief Scientific Officer/高管/, 操作:买入,500(股)Common Stock,均价$5.0223; 报告日:2018-11-29, SEC Accession No. 0001104659-18-070795, File:https://www.sec.gov/Archives/edgar/data/1720893/000110465918070795/0001104659-18-070795-index.htm $BioXcel(BTAI)$
查看全文

BioXcel(BTAI) 12月01日 03时58分

公告 BioXcel Therapeutics, Inc. - SEC Form 4 - Statement of changes in beneficial ownership of securities:.内部交易 报告人:Steinhart Richard I
公告日:2018-11-30, 内部交易人:Steinhart Richard I, 与发行人关系:Chief Financial Officer/高管/, 操作:买入,500(股)Common Stock,均价$5.0000; 报告日:2018-11-29, SEC Accession No. 0001104659-18-070793, File:https://www.sec.gov/Archives/edgar/data/1720893/000110465918070793/0001104659-18-070793-index.htm $BioXcel(BTAI)$
查看全文

BioXcel(BTAI) 11月16日 19时04分

BioXcel(BTAI) 11月16日 19时04分

查看全文

BioXcel(BTAI) 11月16日 19时04分

  • 首页 上一页 1 2 3 下一页 尾页  每页20条/共108